Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HIV-1 | 53 | 2024 | 6962 | 5.310 |
Why?
|
Viral Load | 49 | 2024 | 3398 | 4.820 |
Why?
|
HIV Infections | 79 | 2024 | 17591 | 4.720 |
Why?
|
Anti-HIV Agents | 29 | 2024 | 4576 | 3.520 |
Why?
|
Anti-Retroviral Agents | 26 | 2024 | 1795 | 3.220 |
Why?
|
Viremia | 19 | 2023 | 725 | 2.770 |
Why?
|
Drug Resistance, Viral | 19 | 2024 | 869 | 2.580 |
Why?
|
Proviruses | 11 | 2024 | 320 | 2.490 |
Why?
|
Virus Latency | 7 | 2021 | 360 | 1.870 |
Why?
|
Withholding Treatment | 11 | 2021 | 620 | 1.770 |
Why?
|
RNA, Viral | 30 | 2023 | 2871 | 1.380 |
Why?
|
Antibodies, Viral | 18 | 2024 | 3215 | 1.300 |
Why?
|
AIDS Vaccines | 5 | 2022 | 900 | 1.180 |
Why?
|
Antibodies, Neutralizing | 14 | 2024 | 2009 | 1.040 |
Why?
|
Virus Integration | 2 | 2018 | 307 | 0.970 |
Why?
|
Virus Shedding | 2 | 2022 | 110 | 0.940 |
Why?
|
CD8-Positive T-Lymphocytes | 11 | 2024 | 4651 | 0.920 |
Why?
|
DNA, Viral | 13 | 2024 | 2205 | 0.900 |
Why?
|
CD4-Positive T-Lymphocytes | 19 | 2024 | 4413 | 0.890 |
Why?
|
HIV | 5 | 2021 | 1597 | 0.890 |
Why?
|
Reverse Transcriptase Inhibitors | 4 | 2013 | 622 | 0.790 |
Why?
|
HIV Long-Term Survivors | 2 | 2018 | 140 | 0.720 |
Why?
|
Coronavirus | 1 | 2023 | 156 | 0.710 |
Why?
|
Immunocompromised Host | 4 | 2023 | 863 | 0.710 |
Why?
|
Infectious Disease Medicine | 1 | 2020 | 49 | 0.690 |
Why?
|
Humans | 171 | 2024 | 768970 | 0.680 |
Why?
|
Oropharynx | 1 | 2020 | 139 | 0.660 |
Why?
|
Pneumonia, Viral | 7 | 2021 | 3241 | 0.660 |
Why?
|
Acquired Immunodeficiency Syndrome | 3 | 2023 | 2203 | 0.650 |
Why?
|
Antiphospholipid Syndrome | 1 | 2020 | 167 | 0.630 |
Why?
|
Coronavirus Infections | 7 | 2020 | 3118 | 0.630 |
Why?
|
HIV Seropositivity | 2 | 2023 | 967 | 0.620 |
Why?
|
Pregnancy Complications, Infectious | 8 | 2024 | 2190 | 0.620 |
Why?
|
Plasma | 4 | 2022 | 585 | 0.610 |
Why?
|
Virus Replication | 5 | 2023 | 2458 | 0.600 |
Why?
|
Sputum | 1 | 2020 | 517 | 0.580 |
Why?
|
Antiviral Agents | 11 | 2024 | 3070 | 0.580 |
Why?
|
Nasopharynx | 1 | 2020 | 420 | 0.560 |
Why?
|
Obesity, Morbid | 3 | 2022 | 1300 | 0.560 |
Why?
|
Antiretroviral Therapy, Highly Active | 12 | 2024 | 1903 | 0.560 |
Why?
|
Gastric Bypass | 2 | 2022 | 824 | 0.550 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 3 | 2012 | 215 | 0.550 |
Why?
|
Cultural Diversity | 1 | 2020 | 373 | 0.540 |
Why?
|
Nevirapine | 2 | 2013 | 273 | 0.500 |
Why?
|
Treatment Failure | 7 | 2021 | 2664 | 0.490 |
Why?
|
CD4 Lymphocyte Count | 8 | 2020 | 2598 | 0.490 |
Why?
|
DNA Probes | 1 | 2016 | 543 | 0.490 |
Why?
|
Gastroesophageal Reflux | 1 | 2022 | 836 | 0.470 |
Why?
|
Placenta | 5 | 2024 | 1725 | 0.440 |
Why?
|
Pyrrolidinones | 1 | 2014 | 116 | 0.440 |
Why?
|
HIV Antibodies | 5 | 2024 | 1341 | 0.430 |
Why?
|
Leukocytes, Mononuclear | 7 | 2024 | 1855 | 0.420 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2019 | 3671 | 0.420 |
Why?
|
Antibodies, Monoclonal | 11 | 2024 | 9264 | 0.370 |
Why?
|
Remission Induction | 4 | 2021 | 2408 | 0.370 |
Why?
|
Medication Adherence | 2 | 2014 | 2192 | 0.360 |
Why?
|
Antigens, Viral | 3 | 2024 | 996 | 0.360 |
Why?
|
Syphilis | 2 | 2010 | 243 | 0.360 |
Why?
|
Adult | 49 | 2024 | 223851 | 0.360 |
Why?
|
Mutation | 13 | 2024 | 30266 | 0.350 |
Why?
|
Eye Infections | 1 | 2010 | 62 | 0.340 |
Why?
|
Kinetics | 5 | 2024 | 6332 | 0.340 |
Why?
|
Genetic Variation | 3 | 2018 | 6611 | 0.330 |
Why?
|
HIV Reverse Transcriptase | 1 | 2010 | 214 | 0.330 |
Why?
|
Drug Monitoring | 1 | 2015 | 965 | 0.320 |
Why?
|
Clinical Trials as Topic | 4 | 2019 | 8055 | 0.320 |
Why?
|
Pandemics | 13 | 2022 | 8749 | 0.320 |
Why?
|
Male | 58 | 2024 | 365203 | 0.310 |
Why?
|
Encephalitis, Herpes Simplex | 1 | 2009 | 65 | 0.310 |
Why?
|
Post-Exposure Prophylaxis | 2 | 2023 | 113 | 0.300 |
Why?
|
Placebos | 4 | 2014 | 1667 | 0.300 |
Why?
|
Female | 61 | 2024 | 397515 | 0.300 |
Why?
|
Secondary Prevention | 1 | 2014 | 1476 | 0.290 |
Why?
|
Hospitalization | 6 | 2024 | 10847 | 0.290 |
Why?
|
Models, Biological | 2 | 2021 | 9499 | 0.270 |
Why?
|
Middle Aged | 35 | 2024 | 223737 | 0.270 |
Why?
|
Disease Reservoirs | 2 | 2018 | 123 | 0.260 |
Why?
|
Specimen Handling | 2 | 2020 | 708 | 0.250 |
Why?
|
Calciphylaxis | 1 | 2007 | 129 | 0.250 |
Why?
|
Communicable Diseases | 2 | 2023 | 873 | 0.240 |
Why?
|
Killer Cells, Natural | 2 | 2024 | 2211 | 0.230 |
Why?
|
RNA | 3 | 2023 | 2727 | 0.230 |
Why?
|
Fetal Blood | 2 | 2021 | 1361 | 0.230 |
Why?
|
Phylogeny | 4 | 2022 | 2843 | 0.230 |
Why?
|
Infectious Disease Transmission, Vertical | 5 | 2022 | 1360 | 0.230 |
Why?
|
Interferons | 3 | 2022 | 720 | 0.220 |
Why?
|
Soaps | 1 | 2003 | 30 | 0.220 |
Why?
|
Genitalia, Male | 1 | 2003 | 87 | 0.220 |
Why?
|
Herpesvirus 1, Human | 1 | 2009 | 744 | 0.220 |
Why?
|
Lymphocyte Activation | 4 | 2023 | 5505 | 0.210 |
Why?
|
Adenosine Monophosphate | 1 | 2024 | 232 | 0.210 |
Why?
|
Cytokines | 6 | 2024 | 7453 | 0.210 |
Why?
|
Genitalia, Female | 1 | 2003 | 146 | 0.200 |
Why?
|
Virus Cultivation | 1 | 2022 | 88 | 0.200 |
Why?
|
Immunization, Passive | 2 | 2022 | 619 | 0.200 |
Why?
|
Respiratory Syncytial Virus Vaccines | 1 | 2022 | 37 | 0.200 |
Why?
|
Serologic Tests | 2 | 2021 | 382 | 0.200 |
Why?
|
Fetal Distress | 1 | 2022 | 39 | 0.200 |
Why?
|
Streptococcus anginosus | 1 | 2022 | 25 | 0.200 |
Why?
|
Saliva | 3 | 2022 | 854 | 0.200 |
Why?
|
Bariatric Surgery | 2 | 2022 | 1001 | 0.200 |
Why?
|
Virus Activation | 2 | 2021 | 324 | 0.200 |
Why?
|
pol Gene Products, Human Immunodeficiency Virus | 2 | 2012 | 41 | 0.200 |
Why?
|
Hand | 1 | 2007 | 913 | 0.200 |
Why?
|
Severity of Illness Index | 8 | 2021 | 15951 | 0.190 |
Why?
|
Alanine | 1 | 2024 | 614 | 0.190 |
Why?
|
Transcription, Genetic | 1 | 2015 | 7609 | 0.190 |
Why?
|
Treatment Outcome | 16 | 2024 | 65480 | 0.190 |
Why?
|
SAIDS Vaccines | 1 | 2022 | 144 | 0.190 |
Why?
|
Urinary Retention | 1 | 2022 | 107 | 0.180 |
Why?
|
Immune Evasion | 2 | 2023 | 376 | 0.180 |
Why?
|
Phosphoproteins | 3 | 2024 | 2452 | 0.180 |
Why?
|
Fatal Outcome | 2 | 2020 | 1836 | 0.180 |
Why?
|
Polymerase Chain Reaction | 4 | 2021 | 6086 | 0.180 |
Why?
|
Vaccination | 2 | 2022 | 3438 | 0.180 |
Why?
|
Hernia, Ventral | 1 | 2024 | 220 | 0.170 |
Why?
|
Immunity, Maternally-Acquired | 1 | 2020 | 112 | 0.170 |
Why?
|
Decision Support Systems, Clinical | 2 | 2019 | 1178 | 0.170 |
Why?
|
Time Factors | 8 | 2023 | 40261 | 0.170 |
Why?
|
Fetal Death | 1 | 2022 | 434 | 0.170 |
Why?
|
Pneumonia | 2 | 2011 | 2164 | 0.170 |
Why?
|
Epitope Mapping | 1 | 2020 | 300 | 0.170 |
Why?
|
Cohort Studies | 13 | 2024 | 41808 | 0.170 |
Why?
|
Lymphopenia | 1 | 2022 | 300 | 0.160 |
Why?
|
Serine Endopeptidases | 2 | 2021 | 1027 | 0.160 |
Why?
|
Sequence Analysis, DNA | 4 | 2016 | 4785 | 0.160 |
Why?
|
Genotype | 5 | 2021 | 13048 | 0.160 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2021 | 446 | 0.160 |
Why?
|
Virulence Factors | 1 | 2023 | 502 | 0.160 |
Why?
|
Disease Transmission, Infectious | 2 | 2015 | 560 | 0.160 |
Why?
|
Awards and Prizes | 1 | 2023 | 365 | 0.160 |
Why?
|
Vascular Diseases | 1 | 2007 | 1163 | 0.160 |
Why?
|
Spinal Cord Diseases | 1 | 2022 | 293 | 0.160 |
Why?
|
Virulence | 1 | 2023 | 1298 | 0.160 |
Why?
|
Hernia, Inguinal | 1 | 2022 | 225 | 0.160 |
Why?
|
Sexual Partners | 2 | 2022 | 807 | 0.160 |
Why?
|
Skin Diseases | 1 | 2007 | 1085 | 0.160 |
Why?
|
South Africa | 2 | 2022 | 1872 | 0.160 |
Why?
|
Drug Administration Schedule | 4 | 2019 | 4862 | 0.160 |
Why?
|
Defective Viruses | 1 | 2018 | 89 | 0.150 |
Why?
|
Immunoglobulin G | 4 | 2023 | 4568 | 0.150 |
Why?
|
Immunotherapy | 2 | 2012 | 4756 | 0.150 |
Why?
|
Stochastic Processes | 1 | 2019 | 360 | 0.150 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2020 | 340 | 0.150 |
Why?
|
Biological Clocks | 1 | 2020 | 321 | 0.150 |
Why?
|
Germinal Center | 1 | 2020 | 380 | 0.140 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2021 | 3116 | 0.140 |
Why?
|
Cerebral Hemorrhage | 1 | 2009 | 2660 | 0.140 |
Why?
|
Interferon Type I | 1 | 2021 | 569 | 0.140 |
Why?
|
Virus Internalization | 1 | 2021 | 503 | 0.140 |
Why?
|
Sirolimus | 1 | 2024 | 1540 | 0.140 |
Why?
|
Interleukin-10 | 1 | 2022 | 1183 | 0.140 |
Why?
|
Phospholipids | 1 | 2021 | 787 | 0.140 |
Why?
|
Troponin | 1 | 2020 | 535 | 0.140 |
Why?
|
Lamivudine | 1 | 2018 | 367 | 0.140 |
Why?
|
Drug Therapy, Combination | 2 | 2024 | 6320 | 0.130 |
Why?
|
Weight Loss | 3 | 2022 | 2721 | 0.130 |
Why?
|
Outpatients | 1 | 2024 | 1603 | 0.130 |
Why?
|
Papillomavirus Vaccines | 1 | 2022 | 497 | 0.130 |
Why?
|
Likelihood Functions | 1 | 2019 | 994 | 0.130 |
Why?
|
AIDS Dementia Complex | 1 | 2017 | 155 | 0.130 |
Why?
|
Cannabis | 1 | 2022 | 446 | 0.130 |
Why?
|
Computational Biology | 2 | 2019 | 3562 | 0.130 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2018 | 296 | 0.120 |
Why?
|
Microglia | 1 | 2024 | 1376 | 0.120 |
Why?
|
Community-Acquired Infections | 2 | 2011 | 472 | 0.120 |
Why?
|
Immunity, Cellular | 1 | 2021 | 1560 | 0.120 |
Why?
|
Influenza Vaccines | 1 | 2022 | 781 | 0.120 |
Why?
|
Medicine | 1 | 2023 | 947 | 0.120 |
Why?
|
Respiratory Insufficiency | 1 | 2023 | 1241 | 0.120 |
Why?
|
Kidney Failure, Chronic | 1 | 2007 | 2493 | 0.120 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2020 | 977 | 0.120 |
Why?
|
Phosphatidylcholines | 2 | 2021 | 406 | 0.120 |
Why?
|
Surgical Wound Infection | 1 | 2024 | 1547 | 0.120 |
Why?
|
Genome, Viral | 1 | 2018 | 673 | 0.120 |
Why?
|
Evolution, Molecular | 2 | 2021 | 1894 | 0.120 |
Why?
|
Cytological Techniques | 1 | 2016 | 218 | 0.120 |
Why?
|
Lymphoid Progenitor Cells | 1 | 2014 | 21 | 0.110 |
Why?
|
Macrophages | 3 | 2024 | 5801 | 0.110 |
Why?
|
Epitopes | 1 | 2020 | 2529 | 0.110 |
Why?
|
Aged | 12 | 2024 | 171786 | 0.110 |
Why?
|
Anti-Bacterial Agents | 3 | 2011 | 7478 | 0.110 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2020 | 1495 | 0.110 |
Why?
|
Leadership | 1 | 2022 | 1396 | 0.110 |
Why?
|
Interferon-gamma | 1 | 2021 | 3163 | 0.100 |
Why?
|
HIV Long Terminal Repeat | 1 | 2012 | 86 | 0.100 |
Why?
|
Prospective Studies | 6 | 2024 | 54962 | 0.100 |
Why?
|
Postpartum Period | 1 | 2019 | 1198 | 0.100 |
Why?
|
Viral Tropism | 1 | 2013 | 102 | 0.100 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2023 | 10400 | 0.100 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1469 | 0.100 |
Why?
|
DNA, Circular | 1 | 2012 | 97 | 0.100 |
Why?
|
T-Lymphocytes | 2 | 2020 | 10276 | 0.100 |
Why?
|
Periodicals as Topic | 1 | 2023 | 1470 | 0.100 |
Why?
|
Recurrence | 3 | 2024 | 8513 | 0.100 |
Why?
|
Chemoprevention | 1 | 2014 | 326 | 0.100 |
Why?
|
Alkynes | 1 | 2012 | 327 | 0.100 |
Why?
|
Pregnancy | 9 | 2024 | 30265 | 0.100 |
Why?
|
Molecular Sequence Data | 3 | 2014 | 17629 | 0.090 |
Why?
|
Ritonavir | 2 | 2023 | 332 | 0.090 |
Why?
|
Cyclopropanes | 1 | 2012 | 437 | 0.090 |
Why?
|
Patient Participation | 1 | 2020 | 1448 | 0.090 |
Why?
|
Proteome | 1 | 2021 | 1891 | 0.090 |
Why?
|
Benzoxazines | 1 | 2012 | 321 | 0.090 |
Why?
|
Fetus | 3 | 2024 | 1882 | 0.090 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2017 | 823 | 0.090 |
Why?
|
Antigens | 1 | 2016 | 1444 | 0.090 |
Why?
|
Cardiolipins | 1 | 2010 | 83 | 0.090 |
Why?
|
Leukemia Virus, Murine | 1 | 2010 | 95 | 0.090 |
Why?
|
Retroviridae Infections | 1 | 2010 | 148 | 0.090 |
Why?
|
DNA | 1 | 2024 | 7214 | 0.090 |
Why?
|
Laparoscopy | 1 | 2022 | 2055 | 0.090 |
Why?
|
Drug Combinations | 3 | 2024 | 2089 | 0.090 |
Why?
|
Rectum | 1 | 2014 | 900 | 0.080 |
Why?
|
Vaccines, Synthetic | 1 | 2012 | 622 | 0.080 |
Why?
|
Patient Education as Topic | 1 | 2019 | 2339 | 0.080 |
Why?
|
Patient-Centered Care | 1 | 2019 | 1447 | 0.080 |
Why?
|
Fatigue Syndrome, Chronic | 1 | 2010 | 217 | 0.080 |
Why?
|
Stem Cell Transplantation | 2 | 2017 | 1602 | 0.080 |
Why?
|
Immunologic Memory | 1 | 2015 | 1378 | 0.080 |
Why?
|
Gene Dosage | 1 | 2012 | 1222 | 0.080 |
Why?
|
Acyclovir | 1 | 2009 | 267 | 0.080 |
Why?
|
Substance Abuse, Intravenous | 1 | 2013 | 530 | 0.080 |
Why?
|
Flow Cytometry | 3 | 2015 | 5906 | 0.080 |
Why?
|
Tumor Virus Infections | 1 | 2010 | 437 | 0.070 |
Why?
|
Chromosome Mapping | 1 | 2016 | 4625 | 0.070 |
Why?
|
Sex Factors | 1 | 2021 | 10633 | 0.070 |
Why?
|
Myocardium | 1 | 2020 | 4790 | 0.070 |
Why?
|
Heart Diseases | 1 | 2020 | 2819 | 0.070 |
Why?
|
Antibody Formation | 2 | 2023 | 1393 | 0.070 |
Why?
|
Eye Infections, Bacterial | 1 | 2010 | 239 | 0.070 |
Why?
|
Proteomics | 1 | 2021 | 3914 | 0.070 |
Why?
|
Cerebrospinal Fluid | 1 | 2010 | 545 | 0.070 |
Why?
|
Influenza A virus | 2 | 2021 | 460 | 0.070 |
Why?
|
Immunoglobulin M | 2 | 2023 | 1528 | 0.070 |
Why?
|
Gastrectomy | 2 | 2022 | 693 | 0.070 |
Why?
|
Cell Line | 2 | 2023 | 15604 | 0.070 |
Why?
|
Adenoviridae | 1 | 2011 | 1095 | 0.070 |
Why?
|
Practice Guidelines as Topic | 2 | 2021 | 7460 | 0.070 |
Why?
|
Immune System | 1 | 2012 | 800 | 0.070 |
Why?
|
Drug Carriers | 1 | 2011 | 710 | 0.070 |
Why?
|
Leukocyte Count | 1 | 2010 | 1609 | 0.070 |
Why?
|
United States | 4 | 2022 | 73186 | 0.070 |
Why?
|
Animals | 8 | 2024 | 169335 | 0.060 |
Why?
|
Hyperparathyroidism | 1 | 2007 | 339 | 0.060 |
Why?
|
San Francisco | 2 | 2019 | 166 | 0.060 |
Why?
|
Immunity | 2 | 2021 | 1003 | 0.060 |
Why?
|
Lab-On-A-Chip Devices | 2 | 2022 | 446 | 0.060 |
Why?
|
HLA Antigens | 1 | 2011 | 1336 | 0.060 |
Why?
|
Retrospective Studies | 9 | 2024 | 81903 | 0.060 |
Why?
|
Infant | 3 | 2022 | 36556 | 0.060 |
Why?
|
Clinical Laboratory Techniques | 2 | 2020 | 749 | 0.060 |
Why?
|
Communicable Disease Control | 2 | 2022 | 857 | 0.060 |
Why?
|
Cells, Cultured | 2 | 2021 | 19023 | 0.060 |
Why?
|
Databases, Factual | 1 | 2020 | 8094 | 0.060 |
Why?
|
Research Design | 1 | 2020 | 6214 | 0.060 |
Why?
|
Massachusetts | 4 | 2020 | 8894 | 0.060 |
Why?
|
Transplantation, Homologous | 1 | 2013 | 4835 | 0.060 |
Why?
|
Infusions, Intravenous | 1 | 2009 | 2231 | 0.060 |
Why?
|
Infant, Newborn | 5 | 2021 | 26428 | 0.060 |
Why?
|
T-Lymphocyte Subsets | 2 | 2022 | 1813 | 0.060 |
Why?
|
Counseling | 1 | 2012 | 1554 | 0.060 |
Why?
|
Reproducibility of Results | 3 | 2021 | 20245 | 0.050 |
Why?
|
Telemedicine | 1 | 2020 | 3110 | 0.050 |
Why?
|
Postoperative Complications | 2 | 2022 | 15889 | 0.050 |
Why?
|
Receptors, CCR5 | 2 | 2017 | 491 | 0.050 |
Why?
|
Surgical Wound Dehiscence | 1 | 2024 | 216 | 0.050 |
Why?
|
Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2022 | 52 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5375 | 0.050 |
Why?
|
Half-Life | 1 | 2023 | 651 | 0.050 |
Why?
|
Convalescence | 1 | 2022 | 109 | 0.050 |
Why?
|
Interleukin-7 | 1 | 2022 | 146 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6547 | 0.050 |
Why?
|
Mice | 5 | 2024 | 82072 | 0.050 |
Why?
|
Measles-Mumps-Rubella Vaccine | 1 | 2022 | 71 | 0.050 |
Why?
|
Case-Control Studies | 3 | 2020 | 22296 | 0.050 |
Why?
|
Algorithms | 2 | 2019 | 14201 | 0.050 |
Why?
|
Memory Disorders | 1 | 2009 | 1202 | 0.050 |
Why?
|
Postoperative Nausea and Vomiting | 1 | 2022 | 128 | 0.050 |
Why?
|
Habits | 1 | 2022 | 148 | 0.050 |
Why?
|
Inflammation | 4 | 2022 | 10868 | 0.050 |
Why?
|
Genetic Vectors | 1 | 2011 | 3412 | 0.050 |
Why?
|
Vero Cells | 1 | 2022 | 486 | 0.050 |
Why?
|
Cholesterol | 1 | 2010 | 2913 | 0.050 |
Why?
|
Surgical Mesh | 1 | 2024 | 316 | 0.050 |
Why?
|
Lysophosphatidylcholines | 1 | 2021 | 77 | 0.050 |
Why?
|
Interleukin-6 | 2 | 2021 | 3232 | 0.050 |
Why?
|
Chorioamnionitis | 1 | 2022 | 156 | 0.050 |
Why?
|
Recombinases | 1 | 2020 | 70 | 0.040 |
Why?
|
Neutralization Tests | 1 | 2022 | 739 | 0.040 |
Why?
|
Administration, Inhalation | 1 | 2023 | 1169 | 0.040 |
Why?
|
Biological Assay | 1 | 2023 | 628 | 0.040 |
Why?
|
Prognosis | 1 | 2021 | 30046 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 4592 | 0.040 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2021 | 306 | 0.040 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 2020 | 223 | 0.040 |
Why?
|
Limit of Detection | 1 | 2021 | 277 | 0.040 |
Why?
|
Glycomics | 1 | 2021 | 118 | 0.040 |
Why?
|
Immunity, Innate | 2 | 2022 | 3080 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2020 | 190 | 0.040 |
Why?
|
Young Adult | 7 | 2021 | 60131 | 0.040 |
Why?
|
Single-Blind Method | 1 | 2023 | 1586 | 0.040 |
Why?
|
Interleukin-18 | 1 | 2021 | 251 | 0.040 |
Why?
|
Vasopressins | 1 | 2021 | 358 | 0.040 |
Why?
|
BCG Vaccine | 1 | 2022 | 383 | 0.040 |
Why?
|
Platinum | 1 | 2020 | 222 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12095 | 0.040 |
Why?
|
Lung | 3 | 2023 | 10099 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2021 | 59739 | 0.040 |
Why?
|
Double-Blind Method | 2 | 2023 | 12467 | 0.040 |
Why?
|
Statistics, Nonparametric | 2 | 2015 | 2862 | 0.040 |
Why?
|
Risk | 1 | 2011 | 9621 | 0.040 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2014 | 5716 | 0.040 |
Why?
|
Patient Selection | 2 | 2021 | 4265 | 0.040 |
Why?
|
Virion | 1 | 2020 | 430 | 0.040 |
Why?
|
Cross Reactions | 1 | 2020 | 828 | 0.040 |
Why?
|
Genes, env | 1 | 2018 | 95 | 0.040 |
Why?
|
HIV Envelope Protein gp160 | 1 | 2018 | 96 | 0.040 |
Why?
|
Quality of Life | 1 | 2020 | 13510 | 0.040 |
Why?
|
HIV Protease Inhibitors | 1 | 2020 | 432 | 0.040 |
Why?
|
Abscess | 1 | 2022 | 606 | 0.040 |
Why?
|
Perinatal Care | 1 | 2020 | 246 | 0.040 |
Why?
|
Child | 6 | 2022 | 80960 | 0.040 |
Why?
|
Signal Transduction | 1 | 2021 | 23653 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1737 | 0.040 |
Why?
|
Arteries | 1 | 2022 | 1126 | 0.040 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2021 | 794 | 0.040 |
Why?
|
Immunomodulation | 1 | 2021 | 549 | 0.030 |
Why?
|
Water | 1 | 2003 | 1421 | 0.030 |
Why?
|
Chemokines | 1 | 2021 | 963 | 0.030 |
Why?
|
Brazil | 1 | 2021 | 1250 | 0.030 |
Why?
|
Advisory Committees | 1 | 2021 | 797 | 0.030 |
Why?
|
Chromosomes, Human | 1 | 2019 | 438 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2022 | 15661 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2021 | 1866 | 0.030 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2022 | 621 | 0.030 |
Why?
|
Radiography | 1 | 2007 | 6991 | 0.030 |
Why?
|
Protein Binding | 2 | 2021 | 9344 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2021 | 1742 | 0.030 |
Why?
|
Pilot Projects | 2 | 2021 | 8748 | 0.030 |
Why?
|
Metal Nanoparticles | 1 | 2020 | 406 | 0.030 |
Why?
|
Cryoelectron Microscopy | 1 | 2020 | 649 | 0.030 |
Why?
|
Cell Cycle | 1 | 2024 | 2937 | 0.030 |
Why?
|
Administration, Oral | 1 | 2024 | 4040 | 0.030 |
Why?
|
Seizures | 1 | 2009 | 3000 | 0.030 |
Why?
|
Oxazines | 1 | 2018 | 358 | 0.030 |
Why?
|
Educational Status | 1 | 2023 | 2515 | 0.030 |
Why?
|
Gastrointestinal Tract | 1 | 2022 | 840 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1105 | 0.030 |
Why?
|
Feces | 1 | 2022 | 1510 | 0.030 |
Why?
|
Enzyme-Linked Immunospot Assay | 1 | 2015 | 126 | 0.030 |
Why?
|
Antibodies | 1 | 2023 | 2422 | 0.030 |
Why?
|
Interprofessional Relations | 1 | 2021 | 997 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2022 | 1803 | 0.030 |
Why?
|
Research | 1 | 2023 | 1981 | 0.030 |
Why?
|
Gene Products, gag | 1 | 2015 | 317 | 0.030 |
Why?
|
Phenotype | 1 | 2013 | 16731 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2023 | 2149 | 0.030 |
Why?
|
Disaster Planning | 1 | 2020 | 559 | 0.030 |
Why?
|
Schools | 1 | 2023 | 1498 | 0.030 |
Why?
|
Spleen | 1 | 2020 | 2294 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1794 | 0.030 |
Why?
|
Drug Therapy | 1 | 2017 | 504 | 0.030 |
Why?
|
Bacterial Translocation | 1 | 2014 | 74 | 0.030 |
Why?
|
Disease Progression | 2 | 2023 | 13674 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2021 | 1625 | 0.030 |
Why?
|
Drug Approval | 1 | 2021 | 821 | 0.030 |
Why?
|
Nigeria | 1 | 2017 | 779 | 0.030 |
Why?
|
Age Factors | 2 | 2020 | 18435 | 0.030 |
Why?
|
HIV Antigens | 1 | 2014 | 328 | 0.030 |
Why?
|
Cell Survival | 1 | 2003 | 5793 | 0.030 |
Why?
|
Needle Sharing | 1 | 2013 | 22 | 0.030 |
Why?
|
Needle-Exchange Programs | 1 | 2013 | 27 | 0.030 |
Why?
|
Cytomegalovirus | 1 | 2017 | 753 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2022 | 20776 | 0.030 |
Why?
|
Protein Conformation | 1 | 2020 | 3956 | 0.030 |
Why?
|
Pyridones | 1 | 2018 | 819 | 0.030 |
Why?
|
Receptors, HIV | 1 | 2013 | 159 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2021 | 1890 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2023 | 2725 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2022 | 2960 | 0.020 |
Why?
|
Metabolomics | 1 | 2021 | 1675 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14752 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2021 | 4290 | 0.020 |
Why?
|
Herpesvirus 4, Human | 1 | 2017 | 1082 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2021 | 2714 | 0.020 |
Why?
|
Pain, Postoperative | 1 | 2022 | 1767 | 0.020 |
Why?
|
Condoms | 1 | 2013 | 338 | 0.020 |
Why?
|
env Gene Products, Human Immunodeficiency Virus | 1 | 2014 | 381 | 0.020 |
Why?
|
Cytomegalovirus Infections | 1 | 2017 | 839 | 0.020 |
Why?
|
Prevalence | 2 | 2020 | 15879 | 0.020 |
Why?
|
Cross-Sectional Studies | 3 | 2021 | 26395 | 0.020 |
Why?
|
Hospitals, Public | 1 | 2011 | 204 | 0.020 |
Why?
|
Species Specificity | 1 | 2014 | 2417 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2021 | 3709 | 0.020 |
Why?
|
Hospitals, Urban | 1 | 2011 | 499 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2020 | 4356 | 0.020 |
Why?
|
Gene Expression | 1 | 2021 | 7603 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3859 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2021 | 9565 | 0.020 |
Why?
|
Transplantation Immunology | 1 | 2010 | 537 | 0.020 |
Why?
|
Critical Illness | 1 | 2021 | 2754 | 0.020 |
Why?
|
Neoplasms | 1 | 2017 | 22389 | 0.020 |
Why?
|
Health Personnel | 1 | 2022 | 3383 | 0.020 |
Why?
|
Child, Preschool | 2 | 2021 | 42683 | 0.020 |
Why?
|
Adolescent | 3 | 2021 | 89244 | 0.020 |
Why?
|
Piperazines | 1 | 2018 | 2553 | 0.020 |
Why?
|
Public Health | 1 | 2020 | 2680 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2021 | 11116 | 0.020 |
Why?
|
Internet | 1 | 2019 | 3112 | 0.020 |
Why?
|
Risk-Taking | 1 | 2013 | 1023 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2020 | 4794 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2014 | 2732 | 0.020 |
Why?
|
China | 1 | 2013 | 2395 | 0.020 |
Why?
|
Hodgkin Disease | 1 | 2014 | 1384 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12562 | 0.020 |
Why?
|
Heterozygote | 1 | 2013 | 2798 | 0.020 |
Why?
|
Anemia, Sickle Cell | 1 | 2014 | 1065 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10592 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2024 | 9442 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2021 | 9549 | 0.020 |
Why?
|
Gene Deletion | 1 | 2013 | 2674 | 0.020 |
Why?
|
Myelodysplastic Syndromes | 1 | 2014 | 1399 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2020 | 14794 | 0.010 |
Why?
|
Bacteremia | 1 | 2011 | 985 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2017 | 7148 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2020 | 9080 | 0.010 |
Why?
|
Incidence | 1 | 2022 | 21547 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2021 | 11932 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2014 | 3044 | 0.010 |
Why?
|
Sexual Behavior | 1 | 2013 | 2200 | 0.010 |
Why?
|
Base Sequence | 1 | 2014 | 12430 | 0.010 |
Why?
|
Transcription Factors | 1 | 2021 | 12174 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 12801 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2021 | 18354 | 0.010 |
Why?
|
Boston | 1 | 2014 | 9377 | 0.010 |
Why?
|
Organ Transplantation | 1 | 2010 | 1178 | 0.010 |
Why?
|
Survival Analysis | 1 | 2011 | 10115 | 0.010 |
Why?
|
Brain | 1 | 2024 | 27453 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2011 | 5369 | 0.010 |
Why?
|
Risk Factors | 2 | 2014 | 74976 | 0.010 |
Why?
|
Arthritis, Rheumatoid | 1 | 2010 | 3780 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2011 | 15471 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2022 | 36854 | 0.010 |
Why?
|